A
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Price:
8 020
KRW
-3.02%
Market Closed
Market Cap:
91.2B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Ahn-Gook Pharmaceutical Co Ltd
8020
-250 (-3.02%)
| 52 Week Range |
6 310
9 200
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
Delete Alert
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Ahn-Gook Pharmaceutical Co Ltd
Ahn-Gook Pharmaceutical Co Ltd
| Current Assets | 134.3B |
| Cash & Short-Term Investments | 53.2B |
| Receivables | 33.8B |
| Other Current Assets | 47.3B |
| Non-Current Assets | 169.1B |
| Long-Term Investments | 41B |
| PP&E | 119.6B |
| Intangibles | 3.7B |
| Other Non-Current Assets | 4.8B |
| Current Liabilities | 75B |
| Accounts Payable | 13.1B |
| Accrued Liabilities | 13.9B |
| Short-Term Debt | 22.3B |
| Other Current Liabilities | 25.7B |
| Non-Current Liabilities | 60.1B |
| Long-Term Debt | 50.3B |
| Other Non-Current Liabilities | 9.8B |
Balance Sheet
Ahn-Gook Pharmaceutical Co Ltd
Ahn-Gook Pharmaceutical Co Ltd
Currency: KRW
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
2 538
|
1 858
|
1 468
|
2 566
|
5 126
|
5 509
|
650
|
1 153
|
358
|
2 179
|
4 946
|
8 419
|
4 359
|
5 460
|
19 260
|
21 388
|
22 640
|
21 472
|
22 746
|
12 768
|
13 650
|
18 219
|
28 991
|
15 844
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
86
|
28
|
87
|
6
|
6
|
0
|
1
|
1 559
|
2 874
|
10 343
|
11 694
|
6 065
|
|
| Cash Equivalents |
2 538
|
1 858
|
1 468
|
2 566
|
5 126
|
5 509
|
650
|
1 153
|
358
|
2 179
|
4 946
|
8 419
|
4 273
|
5 432
|
19 173
|
21 382
|
22 634
|
21 472
|
22 745
|
11 209
|
10 775
|
7 876
|
17 297
|
9 779
|
|
| Short-Term Investments |
4 642
|
14 658
|
14 734
|
16 789
|
21 652
|
21 730
|
29 115
|
19 624
|
24 285
|
37 493
|
41 687
|
38 199
|
26 378
|
19 539
|
28 655
|
21 141
|
25 388
|
33 279
|
56 604
|
35 824
|
32 559
|
17 873
|
6 455
|
13 894
|
|
| Total Receivables |
14 869
|
14 421
|
16 615
|
16 590
|
21 540
|
22 152
|
25 263
|
28 691
|
36 964
|
35 751
|
38 200
|
38 795
|
42 080
|
53 604
|
63 542
|
57 061
|
62 548
|
69 201
|
47 288
|
37 893
|
44 159
|
55 597
|
62 753
|
59 015
|
|
| Accounts Receivables |
14 199
|
13 590
|
14 951
|
15 110
|
19 159
|
19 349
|
22 621
|
24 920
|
32 658
|
35 751
|
38 200
|
38 795
|
36 585
|
47 713
|
60 287
|
54 029
|
58 571
|
69 200
|
45 810
|
33 104
|
43 381
|
54 955
|
62 169
|
58 722
|
|
| Other Receivables |
670
|
831
|
1 664
|
1 480
|
2 381
|
2 803
|
2 642
|
3 771
|
4 306
|
0
|
0
|
0
|
5 495
|
5 891
|
3 255
|
3 032
|
3 977
|
1
|
1 478
|
4 789
|
778
|
642
|
584
|
293
|
|
| Inventory |
1 561
|
1 615
|
2 218
|
3 561
|
2 819
|
4 999
|
5 108
|
7 624
|
17 739
|
13 626
|
26 407
|
27 708
|
34 130
|
37 337
|
24 998
|
20 710
|
19 932
|
21 670
|
23 505
|
22 669
|
23 891
|
26 594
|
35 718
|
44 672
|
|
| Other Current Assets |
98
|
76
|
196
|
241
|
834
|
2 423
|
2 566
|
3 454
|
1 905
|
3 190
|
2 883
|
813
|
465
|
3 381
|
1 751
|
2 709
|
2 710
|
3 146
|
1 996
|
2 278
|
2 025
|
3 728
|
1 499
|
1 347
|
|
| Total Current Assets |
23 708
|
32 628
|
35 231
|
39 747
|
51 970
|
56 814
|
62 703
|
60 544
|
81 251
|
92 240
|
114 123
|
113 933
|
107 412
|
119 322
|
138 207
|
123 008
|
133 218
|
148 767
|
152 139
|
111 432
|
116 285
|
122 010
|
135 416
|
134 772
|
|
| PP&E Net |
12 380
|
11 991
|
12 009
|
13 809
|
13 854
|
15 945
|
19 150
|
20 886
|
28 463
|
46 353
|
40 327
|
40 769
|
45 311
|
49 659
|
49 337
|
50 520
|
49 138
|
46 839
|
48 036
|
70 554
|
70 911
|
70 771
|
73 036
|
120 069
|
|
| PP&E Gross |
12 380
|
11 991
|
12 009
|
13 809
|
13 854
|
15 945
|
19 150
|
20 886
|
28 463
|
46 353
|
40 327
|
40 769
|
45 311
|
49 659
|
49 337
|
50 520
|
49 138
|
46 839
|
48 036
|
70 554
|
70 911
|
70 771
|
73 036
|
120 069
|
|
| Accumulated Depreciation |
3 981
|
4 729
|
5 396
|
6 074
|
7 177
|
8 196
|
9 265
|
10 459
|
11 578
|
13 934
|
15 914
|
17 885
|
19 766
|
22 127
|
24 281
|
27 131
|
30 076
|
32 613
|
36 025
|
36 842
|
39 069
|
22 073
|
39 985
|
37 881
|
|
| Intangible Assets |
85
|
71
|
49
|
55
|
39
|
177
|
244
|
199
|
140
|
4 516
|
4 007
|
4 452
|
3 911
|
2 987
|
3 118
|
2 607
|
2 503
|
4 117
|
3 579
|
3 378
|
3 874
|
4 087
|
4 287
|
3 901
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
72
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
40
|
48
|
75
|
0
|
100
|
100
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1 770
|
909
|
1 028
|
744
|
704
|
701
|
1 728
|
4 535
|
3 869
|
5 727
|
5 145
|
7 034
|
5 751
|
6 230
|
4 812
|
17 567
|
21 253
|
10 298
|
11 099
|
12 694
|
27 346
|
23 503
|
23 384
|
40 679
|
|
| Other Long-Term Assets |
451
|
1 351
|
2 630
|
3 658
|
4 749
|
4 737
|
5 498
|
8 021
|
8 518
|
483
|
253
|
1 647
|
857
|
872
|
2 381
|
2 566
|
1 953
|
2 902
|
3 103
|
3 643
|
1 541
|
3 542
|
2 473
|
3 113
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
72
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
38 394
N/A
|
46 952
+22%
|
50 947
+9%
|
58 053
+14%
|
71 364
+23%
|
78 449
+10%
|
89 322
+14%
|
94 286
+6%
|
122 341
+30%
|
149 391
+22%
|
163 855
+10%
|
167 835
+2%
|
163 242
-3%
|
179 070
+10%
|
197 855
+10%
|
196 267
-1%
|
208 065
+6%
|
212 924
+2%
|
217 957
+2%
|
201 702
-7%
|
219 956
+9%
|
223 912
+2%
|
238 598
+7%
|
302 535
+27%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
823
|
1 024
|
1 430
|
1 423
|
2 242
|
3 598
|
2 958
|
3 540
|
6 977
|
5 593
|
15 190
|
9 910
|
9 537
|
15 602
|
16 047
|
17 243
|
17 850
|
12 813
|
10 555
|
9 048
|
10 141
|
12 643
|
15 208
|
10 265
|
|
| Accrued Liabilities |
443
|
999
|
971
|
847
|
1 393
|
1 087
|
1 235
|
1 191
|
1 062
|
1 434
|
1 282
|
2 350
|
1 555
|
1 957
|
2 827
|
1 875
|
2 353
|
3 599
|
654
|
1 744
|
7 527
|
8 974
|
10 619
|
12 060
|
|
| Short-Term Debt |
336
|
274
|
0
|
0
|
0
|
0
|
3 239
|
2 188
|
7 336
|
14 749
|
17 782
|
18 097
|
11 263
|
10 851
|
10 000
|
10 000
|
10 000
|
10 000
|
18 000
|
19 900
|
19 600
|
19 450
|
17 300
|
27 300
|
|
| Current Portion of Long-Term Debt |
2 524
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
891
|
2 139
|
167
|
1 828
|
0
|
0
|
125
|
12 823
|
9 916
|
9 513
|
10 418
|
502
|
357
|
345
|
259
|
197
|
|
| Other Current Liabilities |
4 612
|
6 514
|
4 936
|
4 733
|
8 545
|
8 155
|
8 789
|
7 620
|
11 843
|
9 317
|
9 473
|
12 718
|
4 981
|
14 071
|
9 360
|
9 424
|
18 272
|
16 143
|
16 655
|
13 484
|
14 587
|
20 087
|
34 857
|
27 237
|
|
| Total Current Liabilities |
8 737
|
8 811
|
7 337
|
7 004
|
12 180
|
12 840
|
16 221
|
14 539
|
28 109
|
33 233
|
43 894
|
44 903
|
27 335
|
42 481
|
38 359
|
51 365
|
58 391
|
52 068
|
56 282
|
44 678
|
52 212
|
61 498
|
78 242
|
77 059
|
|
| Long-Term Debt |
95
|
94
|
93
|
91
|
89
|
87
|
84
|
6 164
|
4 870
|
2 503
|
1 444
|
751
|
785
|
3 215
|
14 628
|
1 772
|
746
|
568
|
548
|
402
|
234
|
210
|
120
|
50 227
|
|
| Deferred Income Tax |
1 338
|
2 515
|
2 643
|
3 223
|
2 495
|
1 853
|
1 095
|
0
|
0
|
845
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
338
|
563
|
740
|
534
|
736
|
831
|
454
|
495
|
453
|
112
|
45
|
140
|
126
|
421
|
932
|
|
| Other Liabilities |
2 587
|
2 317
|
2 239
|
2 278
|
2 385
|
3 155
|
3 522
|
4 148
|
4 103
|
4 834
|
6 432
|
7 817
|
8 700
|
10 911
|
12 973
|
11 784
|
11 475
|
13 069
|
12 768
|
12 478
|
14 229
|
7 533
|
8 569
|
10 506
|
|
| Total Liabilities |
12 757
N/A
|
13 737
+8%
|
12 311
-10%
|
12 596
+2%
|
17 149
+36%
|
17 935
+5%
|
20 923
+17%
|
24 851
+19%
|
37 082
+49%
|
41 753
+13%
|
52 333
+25%
|
54 212
+4%
|
37 354
-31%
|
57 342
+54%
|
66 793
+16%
|
65 374
-2%
|
71 107
+9%
|
66 157
-7%
|
69 710
+5%
|
57 603
-17%
|
66 535
+16%
|
69 115
+4%
|
86 511
+25%
|
136 860
+58%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
5 750
|
5 750
|
5 750
|
5 750
|
5 750
|
5 750
|
5 750
|
5 750
|
5 750
|
5 750
|
5 805
|
5 835
|
6 355
|
6 465
|
6 521
|
6 521
|
6 521
|
6 521
|
6 521
|
6 521
|
6 521
|
6 521
|
6 521
|
6 521
|
|
| Retained Earnings |
9 587
|
16 563
|
23 749
|
31 401
|
40 118
|
47 345
|
55 116
|
61 657
|
70 971
|
99 335
|
104 219
|
106 323
|
111 514
|
107 021
|
113 597
|
113 716
|
119 701
|
129 903
|
130 170
|
126 215
|
127 754
|
133 487
|
131 553
|
145 070
|
|
| Additional Paid In Capital |
10 724
|
10 724
|
10 724
|
10 724
|
10 724
|
10 794
|
10 857
|
10 857
|
10 857
|
4 488
|
4 863
|
4 648
|
10 806
|
11 264
|
13 362
|
13 365
|
13 139
|
13 139
|
14 313
|
14 313
|
14 313
|
14 313
|
14 313
|
14 313
|
|
| Unrealized Security Profit/Loss |
1
|
3
|
2
|
4
|
0
|
1
|
6
|
5 401
|
579
|
931
|
516
|
284
|
109
|
209
|
158
|
35
|
356
|
63
|
24
|
217
|
8 001
|
4 199
|
3 422
|
3 494
|
|
| Treasury Stock |
423
|
273
|
2 039
|
2 955
|
3 047
|
4 046
|
4 029
|
4 129
|
3 981
|
3 981
|
3 981
|
3 978
|
3 977
|
3 969
|
3 973
|
3 969
|
3 967
|
3 952
|
3 952
|
3 967
|
4 387
|
4 941
|
4 941
|
4 941
|
|
| Other Equity |
0
|
454
|
454
|
541
|
670
|
670
|
700
|
701
|
1 084
|
1 114
|
1 131
|
1 078
|
1 081
|
1 156
|
1 397
|
1 225
|
1 209
|
1 218
|
1 218
|
1 233
|
1 218
|
1 218
|
1 218
|
1 218
|
|
| Total Equity |
25 637
N/A
|
33 215
+30%
|
38 636
+16%
|
45 457
+18%
|
54 215
+19%
|
60 514
+12%
|
68 400
+13%
|
69 435
+2%
|
85 260
+23%
|
107 637
+26%
|
111 522
+4%
|
113 623
+2%
|
125 888
+11%
|
121 728
-3%
|
131 062
+8%
|
130 893
0%
|
136 958
+5%
|
146 766
+7%
|
148 247
+1%
|
144 098
-3%
|
153 421
+6%
|
154 798
+1%
|
152 086
-2%
|
165 676
+9%
|
|
| Total Liabilities & Equity |
38 394
N/A
|
46 952
+22%
|
50 947
+9%
|
58 053
+14%
|
71 364
+23%
|
78 449
+10%
|
89 322
+14%
|
94 286
+6%
|
122 341
+30%
|
149 391
+22%
|
163 855
+10%
|
167 835
+2%
|
163 242
-3%
|
179 070
+10%
|
197 855
+10%
|
196 267
-1%
|
208 065
+6%
|
212 924
+2%
|
217 957
+2%
|
201 702
-7%
|
219 956
+9%
|
223 912
+2%
|
238 598
+7%
|
302 535
+27%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
10
|
11
|
10
|
10
|
10
|
10
|
10
|
11
|
10
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|
Switch to:
Switch to:
See Also
Discover More
